A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers
Clinical trial NCT02678988 · COMPLETED
Trial details
- NCT number
- NCT02678988
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.